A phase I randomized controlled trial to evaluate safety and clinical effect of topically applied GSK2981278 ointment in a psoriasis plaque test

Br J Dermatol. 2018 Jun;178(6):1427-1429. doi: 10.1111/bjd.16131. Epub 2018 Mar 23.
No abstract available

Publication types

  • Clinical Trial, Phase I
  • Letter
  • Randomized Controlled Trial

MeSH terms

  • Administration, Cutaneous
  • Dermatologic Agents / administration & dosage
  • Dermatologic Agents / adverse effects*
  • Double-Blind Method
  • Humans
  • Ointments / administration & dosage
  • Psoriasis / drug therapy*
  • Pyrans / administration & dosage
  • Pyrans / adverse effects*
  • Receptors, Retinoic Acid / agonists*
  • Sulfonamides / administration & dosage
  • Sulfonamides / adverse effects*

Substances

  • Dermatologic Agents
  • GSK2981278
  • Ointments
  • Pyrans
  • Receptors, Retinoic Acid
  • Sulfonamides
  • retinoic acid receptor gamma

Associated data

  • ClinicalTrials.gov/NCT02548052